Opens the fitness cluster. Cardiorespiratory fitness (CRF, peak VO2, measured in METs — 1 MET = 3.5 mL/kg/min) is one of the strongest mortality predictors in medicine — but the wiki’s other lever, physical activity, is measured as dose (minutes); this is measured as the outcome (capacity). The distinction is load-bearing: both sources here are observational, so CRF is a predictor, not a proven causal lever.

The dose-response — each MET matters, and there is no ceiling

  • Per 1-MET higher CRF (Kodama meta-analysis, dose-response): all-cause mortality «RR 0.87 (95% CI, 0.84-0.90)» and CHD/CVD «0.85 (95% CI, 0.82-0.88)» — i.e. «a 1-MET higher level of MAC was associated with 13% and 15% decrements in risk of all-cause mortality and CHD/CVD». [EXTRACTED (Kodama - Cardiorespiratory Fitness and Mortality 2009) chunk 01, Abstract; Comment]
  • No plateau (Mandsager, 122,000-patient cohort): «Cardiorespiratory fitness is inversely associated with long-term mortality with no observed upper limit of benefit» — mortality keeps falling into the elite band: «elite vs high: adjusted HR, 0.77 (95% CI, 0.63-0.95)». [EXTRACTED (Mandsager - Cardiorespiratory Fitness and Long-Term Mortality 2018) chunk 01, Conclusions; Results]

A convergence worth naming, and it bears on the U/J-artifact prior. Self-reported activity studies show a plateau (and sometimes a U-shape) at high volumes; Mandsager, measuring fitness objectively, finds monotone benefit with no plateau, and attributes the discrepancy to «the objective measurement of physical fitness… as opposed to self-reported activity levels». So the activity-plateau may be partly a self-report measurement artifact -> The U-Shaped Association Artifact. Kodama’s own categorical data agree on the shape: the steepest benefit is at the low end (low-vs-high RR 1.70 >> intermediate-vs-high 1.13). [INFERRED (Kodama ...; Mandsager ...) — both report the gradient; the objective-vs-self-report reading of the plateau discrepancy is Mandsager's, extended here to the wiki's U-shape concept]

How big — low fitness outranks smoking and diabetes

Mandsager’s adjusted all-cause-mortality gradient (reference = low performers): «Low vs Elite … 5.04 (4.10-6.20)», «Low vs High … 3.90 (3.67-4.14)», «Low vs Above Average … 2.75», «Low vs Below Average … 1.95». Being unfit is a larger mortality signal than the classic risk factors in the same model: «smoking … 1.41», «diabetes … 1.40», «coronary artery disease … 1.29». Kodama concurs categorically: low-vs-high CRF «RR for all-cause mortality of 1.70 (1.51-1.92)». [EXTRACTED (Mandsager …) chunk 01, Results; Figure 2C; (Kodama …) chunk 01, Abstract]

The target — where a given VO2max sits, by age and sex

There are two anchors the wiki holds:

  • A minimal floor (Kodama): «a minimal CRF of 7.9 METs may be important» (50-year-old man reference); age/sex-specific, «approximately 9 and 7 METs (at 40), 8 and 6 (at 50), 7 and 5 (at 60)» for men and women — women run ~2 METs below men, and the floor falls ~0.1 MET/year with age. [EXTRACTED (Kodama …) chunk 01, Comment; Conclusion]
  • Percentile bands (Mandsager, age x sex MET grid): low (<25th), below-average (25-49th), above-average (50-74th), high (75-97.6th), elite (>=97.7th). E.g. men 50-59: «<8.2 | 8.2-9.9 | 10.0-11.3 | 11.4-13.9 | >=14.0» METs; women 50-59: «<7.0 | 7.0-8.0 | 8.1-9.9 | 10.0-12.9 | >=13.0». [EXTRACTED (Mandsager …) chunk 01, Table 2]

So a VO2max reading converts to METs (/3.5) and drops into a band — the practical is my fitness good? answer the activity-dose evidence cannot give. Caveat: Mandsager’s bands are from a referral population using estimated (treadmill) METs, so a directly-measured VO2max placed against them is approximate.

The load-bearing honesty — predictor, not proven cause

Both sources are observational, and both say so. Kodama: CRF is «associated with» / a «predictor», never «causes», and it «suggest[s]… a clinical trial to determine whether an intervention that improves CRF by exercise reduces the risk». Mandsager: «the association between CRF and mortality does not prove causation… The degree to which high CRF preselects patients with lower mortality vs causes a reduction in mortality is not discernible». [EXTRACTED (Kodama …) chunk 01, Comment; (Mandsager …) chunk 01, Limitations]

So the operative reading: CRF is a superb risk marker and the trackable outcome of the physical- activity lever -> Physical Activity Dose and Mortality (which IS an evidenced mortality lever). But raise your VO2max to live longer is an association, not a demonstrated intervention effect — the proven lever is the activity that raises fitness, and CRF is how you measure whether it worked.

The caveat is partially — not fully — lifted by within-person change (Ross 2016, Measuring and Raising Cardiorespiratory Fitness): people who go from unfit to fit between exams have lower subsequent mortality («44%» in Blair’s cohort), and the one exercise-training RCT (HF-ACTION) links a CRF rise to fewer CV events. Within-person change is a stronger design than the cross-sectional comparison here, so it narrows the reverse-causation worry — but it does not close it (only HF-ACTION is randomized, on a hospitalization-inclusive composite). The upgrade is real and bounded: CRF is a modifiable target whose improvement tracks benefit, not yet a proven cause of longer life.

Limits

  • Not two independent methods. A meta-analysis of cohorts (Kodama) and one mega-cohort (Mandsager) share the observational, confounded, reverse-causation-prone design — this is corroboration and refinement, not an [E-independent] convergence. Kodama’s sensitivity analysis: adjusting for smoking weakened the CHD/CVD link but not the all-cause link (CRF «independently associated with longevity»).
  • Reverse causation is the central threat — subclinical illness lowers fitness; Mandsager’s single time-point measurement cannot separate unfit because sick from sick because unfit.
  • Publication bias in Kodama (Egger p=.002 all-cause), moderately attenuated by trim-and-fill.
  • Transportability of the bands — Mandsager’s referral population is not the general population, and its METs are estimated, not measured.
  • Coherence, not validity (R1): a strong, graded, mechanism-plausible association — but not proof that acting on it changes a given person’s life.